Businesses for Sale

Apparel manufacturing and export business with a 68,500 sq. ft. facility. - Currently operates from one building, while two buildings and adjoining land remain unused. - Seeking to sell two RCC buildings and the land, which are no longer required for operations. - The property includes two adjoined plots with fully constructed buildings and an underground reservoir. - Ideal opportunity for buyers looking for industrial space with ready infrastructure.

Mumbai based private limited consumer electronics company established 4 years ago. - Our skilled engineers have been able to craft product designs from the ground up. - Currently, we have 22 distributors and planning to onboard 50 distribution channel partners by next year. - We provide pan India after-sales service and have onsite after-sales support available at 6,863 pin codes. - Planning for 10,000 onsite after-sales support in pan India in the next 2 years. - Founders have over 12 years of experience in sales, marketing, and the technical field. - YoY sales growth is 100% due to increased demand and portfolio expansion. - Business has a good sales team of 18 members. - have seen a growth in the revenue due to getting more distributors.

Founded by an Orthopaedic surgeon with more than 10 years of experience in the healthcare industry. - Polyclinic, yoga studio and diagnostic centre located in Mumbai providing healthcare solutions by promoting lifestyle modification. - Yoga studio provides services at the centre and online classes over various online platforms. - Internship training programs for allied medical professionals. - Have 2 outpatient department clinics, X-Ray diagnostic, blood investigations. - Have a huge social media following. - Walk-in starting from the very early phase of the business. - Tele-consultations through self-owned app. - Partnering with like-minded healthcare professionals to provide lifestyle modifications on one platform.

Newly established pharmaceutical company, intending to manufacture formulations on a third-party/LL basis to manufacture enzymes or to sell outright. - Manufacturing plant is suitable for manufacturing formulations/ enzymes. - A majority of the set-up has been concluded and only about 50% of the HVAC system is yet to be installed before the plant can be commissioned. - Have already installed several state-of-the-art machines and equipment to ensure high-quality production with minimal manual intervention. - The facility has custom manufacturing capabilities, a separate tablet and capsule section to prevent cross-contamination, blister and strip packing facilities, a micro-lab with MLT, a reference samples room and a stability room. - The facility also has classified clean rooms as per WHO-GMP and other regulatory standards. - The production unit is strategically located 2 hours from Mumbai and its building plan has been approved by MIDC. - Have also obtained MIDC approvals for power and water, pre-FDA approval, consent to establish from MPCB and a NOC for a fire plant. - The facility will be a zero-waste facility with a negative carbon footprint due to the waste management systems and the advanced HVAC systems that incorporate AHUs and Hepa filters. Importantly this facility can be used for manufacturing Enzymes too. - The promoter has 20+ years of experience in the pharmaceutical industry and has already invested INR 5.3 crores into the development. - A thorough market analysis and market mapping exercise has been conducted and the business plan along with the financial projections are available for the investor to peruse.

We are a pharmaceutical marketing company which is based in Chandigarh. - Offer pharmaceutical products range of OTC products like multivitamins, tablets, protein powders, supplements, herbal products, capsules, and syrups. - Have tied-up with 22 third party manufacturers for all our products. - Currently, we have 300+ distributors for our products all over India. - Company has an outstanding loan of INR 50 lakhs and is managed by 2 directors, one of them own 75% stake and the other owns 25% equity stake.